首页>
外国专利>
mammalian monoclonal antibodies against endotoxin of gram negative bacteria and their use in therapy, diagnosis and prophylaxis
mammalian monoclonal antibodies against endotoxin of gram negative bacteria and their use in therapy, diagnosis and prophylaxis
展开▼
机译:革兰氏阴性细菌内毒素的哺乳动物单克隆抗体及其在治疗,诊断和预防中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
Mammalian monoclonal anti-LPS antibodies that react with regions of lipopolysaccharide which are common to the lipopolysaccharide molecules of gram-negative bacteria of different genera are described along with diagnostic and therapeutic uses of the anti-LPS antibodies. The monoclonal anti-LPS antibodies react with gram-negative bacteria across different genera, reacting with regions of the lipid A and/or the core of gram-negative bacterial endotoxin which are shared by virtually all types of gram-negative bacteria. The anti-LPS antibodies protect mice against the lethal effect from gram-negative bacterial infection and neutralize the lethal effect of the endotoxin of gram-negative bacteria in vivo. Also disclosed are immortal antibody-producing cells such as mammalian hybridoma cell lines which generate the monoclonal anti-LPS antibodies. The mammalian monoclonal anti-LPS antibodies are useful in a number of diagnostic and therapeutic applications, including methods for the detection of gram-negative bacteria or endotoxin of gram-negative bacteria, therapy of gram-negative bacterial infection and endotoxin shock in mammals and prophylaxis against bacterial infection in mammals.
展开▼